Dissecting p53 tumor suppressor functions in vivo (Q34135695)

31 July 2017

Dissecting p53 tumor suppressor functions in vivo (English)

1 reference

31 July 2017

5

Robert M Hoffman

1 reference

31 July 2017

Clemens A Schmitt

1

1 reference

31 July 2017

Jordan S Fridman

2

1 reference

31 July 2017

Meng Yang

3

1 reference

31 July 2017

Eugene Baranov

4

1 reference

31 July 2017

Scott W Lowe

6

1 reference

31 July 2017

1 April 2002

1 reference

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

3

1 reference

31 July 2017

289-298

1 reference

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

The role of p53 in tumour suppression: lessons from mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Bcl-2 blocks p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

A p53-dependent mouse spindle checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Proliferation, cell cycle and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Oncogene-dependent apoptosis is mediated by caspase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Cytochrome c depletion upon expression of Bcl-XS.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Molecular biology of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Genomic instability in neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Characterization of the p53-dependent postmitotic checkpoint following spindle disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Genetic analysis of chemoresistance in primary murine lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Mechanisms of p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900047-8

7 January 2021

10.1016/S1535-6108(02)00047-8

Identifiers

DOI

1 reference

31 July 2017

1 reference